Effects of Cocoa Consumption on Cardiometabolic Risk Markers: Meta-Analysis of Randomized Controlled Trials
Nutrients · 2024
DOI: 10.3390/nu16121919 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Nutrients, 2024. Verfasst von Tainah O P Arisi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Cardiologia do Rio Grande do Sul/Fundação Universitária de Cardiologia, Porto Alegre 90620-001, RS, Brazil. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Cacao, Cardiometabolic Risk Factors, Blood Pressure. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
We conducted a systematic review and meta-analysis to examine the effect of dietary intake of cocoa on anthropometric measurements, lipid and glycemic profiles, and blood pressure levels in adults, with and without comorbidities.
Methods
The databases used were MEDLINE (PubMed), EMBASE, Web of Science, Cochrane, LILACS, and SciELO. The eligible studies were randomized clinical trials (RCTs) involving adults undergoing cocoa consumption (cocoa extract or ≥70% cocoa dark chocolate) for ≥4 weeks that evaluated at least one of the following markers: body weight, body mass index (BMI), waist/abdominal circumference, total cholesterol, LDL-c, triglycerides, HDL-c, blood glucose, glycated hemoglobin (HbA1c), and systolic and diastolic blood pressure (SBP/DBP).
Results
Thirty-one studies were included, totaling 1986 participants. Cocoa consumption showed no effects on body weight, BMI, waist circumference, triglycerides, HDL-c and HbA1c. Yet, there was a reduction in total cholesterol (−8.35 mg/dL, 95% CI −14.01; −2.69 mg/dL), LDL-c (−9.47 mg/dL, 95% CI −13.75; −5.20 mg/dL), fasting blood glucose (−4.91 mg/dL, 95% CI −8.29; −1.52 mg/dL), SBP (−2.52 mmHg, 95% CI −4.17; −0.88 mmHg), and DBP (−1.58 mmHg, 95% CI −2.54; −0.62 mmHg).
Conclusions
The consumption of cocoa showed protective effects on major cardiometabolic risk markers that have a clinical impact in terms of cardiovascular risk reduction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Cardiologia do Rio Grande do Sul/Fundação Universitária de Cardiologia, Porto Alegre 90620-001, RS, Brazil.
- Instituto de Pesquisa Hcor (IP-Hcor), Hcor, São Paulo 04005-909, SP, Brazil.
- Faculdade de Saúde Pública, Universidade de São Paulo (FSP-USP), São Paulo 01246-904, SP, Brazil.
ORCID-Profile: Diego Silveira da Silva, Elana Stein, Camila Weschenfelder, Aline Marcadenti
Zitieren
APA
Arisi, T. O. P., da Silva, D. S., Stein, E., Weschenfelder, C., de Oliveira, P. C., Marcadenti, A., Lehnen, A. M., & Waclawovsky, G. (2024). Effects of Cocoa Consumption on Cardiometabolic Risk Markers: Meta-Analysis of Randomized Controlled Trials. Nutrients. https://doi.org/10.3390/nu16121919
Vancouver
Arisi TOP, da Silva DS, Stein E, Weschenfelder C, de Oliveira PC, Marcadenti A, et al. Effects of Cocoa Consumption on Cardiometabolic Risk Markers: Meta-Analysis of Randomized Controlled Trials. Nutrients. 2024. doi:10.3390/nu16121919
BibTeX
@article{Arisi2024,
author = {Arisi, Tainah O P and da Silva, Diego Silveira and Stein, Elana and Weschenfelder, Camila and de Oliveira, Patrícia Caetano and Marcadenti, Aline and Lehnen, Alexandre Machado and Waclawovsky, Gustavo},
title = {Effects of Cocoa Consumption on Cardiometabolic Risk Markers: Meta-Analysis of Randomized Controlled Trials},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16121919}
}
EUVIMED